Vistagen Therapeutics, Inc.
Ticker: 1411685
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.30+15.4% | 0.26+8.3% | 0.24+4.3% | 0.23+27.8% | 0.18+125.0% | 0.08-80.5% | 0.41+46.4% | 0.28 |
| Total Income | 0.30+15.4% | 0.26+8.3% | 0.24+4.3% | 0.23+27.8% | 0.18+125.0% | 0.08-80.5% | 0.41+46.4% | 0.28 |
| EXPENSES | ||||||||
| Expenditure | 19.85-2.3% | 20.31+26.5% | 16.05+4.6% | 15.35+6.5% | 14.41+17.9% | 12.22+47.2% | 8.30+17.6% | 7.06 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.01 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | -18.90+2.7% | -19.42-28.6% | -15.10-7.2% | -14.09-8.8% | -12.95-20.7% | -10.73-69.0% | -6.35+3.6% | -6.59 |
| Net Profit | -18.90+2.7% | -19.42-28.6% | -15.10-7.2% | -14.09-8.7% | -12.96-20.8% | -10.73-69.0% | -6.35+3.6% | -6.59 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.45+16.7% | -0.54-14.9% | -0.47-2.2% | -0.46-9.5% | -0.42-20.0% | -0.35-59.1% | -0.22+66.7% | -0.66 |
Corporate Events
Board MeetingVTGN
202610Sep
Board Meeting
Annual Meeting of Stockholders to elect four directors, appr…
SEC Filing ↗ Board MeetingVTGN
202629Jul
Board Meeting
Appointment of Douglas J. Williamson, M.D. to the Board of D…
SEC Filing ↗ Board MeetingVTGN
202618May
Board Meeting
Appointment of Angel S. Angelov as Chief Medical Officer. O…
SEC Filing ↗ Board MeetingVTGN
20267Apr
Board Meeting
Retention awards granted to Shawn K. Singh, Operating Office…
SEC Filing ↗ Board MeetingVTGN
20267Apr
Board Meeting
Retention awards in the form of stock options granted to key…